Ironwood Pharmaceuticals reported $2.08B in Market Capitalization for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Akebia Therapeutics AKBA:US $ 606.84M 87.23M
Almirall ALM:SM 2.64B 341.48M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amarin AMRN:US 1.73B 715.38M
Ardelyx ARDX:US $ 780.49M 127.23M
Astellas Pharma 4503:JP 3601.63B 432.87B
AstraZeneca AZN:LN 113.99B 18.86B
Astrazeneca AZN:US 157.61B 26.53B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Charles River Laboratories CRL:US $ 18.59B 4.04B
Coherus Biosciences CHRS:US $ 1.05B 20.45M
Emergent Biosolutions EBS:US $ 3.38B 1.6B
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Exact Sciences EXAS:US $ 21.33B 957.64M
Five Prime Therapeutics FPRX:US $ 1.77B 1.02B
Flexion Therapeutics FLXN:US $ 411.02M 35.8M
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Ironwood Pharmaceuticals IRWD:US $ 2.08B 274.12M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Lexicon Pharmaceuticals LXRX:US $ 662.74M 184.62M
Macrogenics MGNX:US $ 1.62B 176.65M
Moderna Inc MRNA:US $ 94.35B 41.95B
Myriad Genetics MYGN:US $ 2.36B 33M
Pacira Pharmaceuticals PCRX:US $ 2.67B 402.93M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Takeda 4502:JP 5869.99B 411.92B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vanda Pharmaceuticals VNDA:US $ 1.2B 370.85M
YTE INCY:US $ 18.5B 632.77M